Cleavage of Lumican by Membrane-Type Matrix Metalloproteinase-1 Abrogates This Proteoglycan-Mediated Suppression of Tumor Cell Colony Formation in Soft Agar
Total Page:16
File Type:pdf, Size:1020Kb
[CANCER RESEARCH 64, 7058–7064, October 1, 2004] Cleavage of Lumican by Membrane-Type Matrix Metalloproteinase-1 Abrogates This Proteoglycan-Mediated Suppression of Tumor Cell Colony Formation in Soft Agar Yingyi Li,1 Takanori Aoki,1,3 Yuya Mori,1 Munirah Ahmad,1 Hisashi Miyamori,1 Takahisa Takino,1 and Hiroshi Sato1,2 1Department of Molecular Virology and Oncology and 2Center for the Development of Molecular Target Drugs, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa, Japan; and 3Daiichi Fine Chemical Co. Ltd., Takaoka, Toyama, Japan ABSTRACT or tumorigenicity in nude mice of rat fibroblast F204 cells trans- formed by K-ras or v-src oncogene (12). The small leucine-rich proteoglycan lumican was identified from a Matrix metalloproteinases (MMPs) are a family of Zn2ϩ-dependent human placenta cDNA library by the expression cloning method as a gene product that interacts with membrane-type matrix metalloproteinase-1 enzymes that are known to cleave extracellular matrix proteins in (MT1-MMP). Coexpression of MT1-MMP with lumican in HEK293T cells normal and pathological conditions (13). Currently, 23 MMP genes reduced the concentration of lumican secreted into culture medium, and have been identified in humans, and they can be subgrouped into this reduction was abolished by addition of the MMP inhibitor BB94. soluble-type and membrane-type MMPs (MT-MMPs; refs. 13, 14). Lumican protein from bovine cornea and recombinant lumican core MMPs are overexpressed in various human malignancies and have protein fused to glutathione S-transferase was shown to be cleaved at been thought to contribute to tumor invasion and metastasis by de- multiple sites by recombinant MT1-MMP. Transient expression of lumi- grading extracellular matrix components (13). Thus, the level of MMP can in HEK293 cells induced expression of tumor suppressor gene product expression correlates with the invasiveness or malignancy of tumors p21/Waf-1, which was abrogated by the coexpression of MT1-MMP con- comitant with a reduction in lumican concentration in culture medium. (15, 16). Particularly, MT1-MMP, MMP-2, MMP-7, and MMP-9 Stable expression of lumican in HeLa cells induced expression of p21 and have been reported to be most closely associated with tumor invasion reduction of colony formation in soft agar, which were both abolished by and metastasis. Although degradation of extracellular matrix is an the expression of MT1-MMP. HT1080 fibrosarcoma cells stably trans- important aspect of MMP biology, growing evidence has shown fected with the lumican cDNA (HT1080/Lum), which express endogenous specific processing/activation or degradation of cell surface receptors MT1-MMP, secreted moderate levels of lumican; however, treatment of and ligands. Fas ligand (17), tumor necrosis factor ␣ (18), the ectodo- HT1080/Lum cells with BB94 resulted in accumulation of lumican in main of the fibroblast growth factor receptor-1 (19), the heparin- culture medium. The expression levels of p21 in HT1080/Lum were pro- portional to the concentration of secreted lumican and showed reverse binding epidermal growth factor (20), and interleukin (IL)-8 (21) were corelation with colony formation in soft agar. These results suggest that reported to be released or activated by MMPs. MMPs also cleave and MT1-MMP abrogates lumican-mediated suppression of tumor cell colony inactivate IL-1 (22), insulin-like growth factor binding proteins (23), formation in soft agar by degrading this proteoglycan, which down- fibrinogen and factor XII (24), the CC chemokine MCP-3 (25), CXC regulates it through the induction of p21. chemokines stromal cell-derived factor 1 ␣ and  (26, 27), metastasis suppressor gene product KiSS-1/metastin (28), and heparan sulfate INTRODUCTION proteglycan syndecan-1 (29). Previously, we have developed an expression cloning method to Lumican belongs to the family of small leucine-rich proteoglycans screen genes, the products of which not only modulate pro-MMP-2 that includes decorin, biglycan, fibromodulin, keratocan, epiphycan, activation mediated by MT1-MMP but also serve as substrates of and osteoglycin. Lumican is the major keratan sulfate proteoglycan of MT1-MMP (28–31). In this study, we have identified lumican as a the corneal stroma, but it is also expressed in other extracellular substrate of MT1-MMP and showed that cleavage of lumican by matrices, such as skin, muscle, and cartilage (1–6). Gene-targeting MT1-MMP suppressed induction of p21/Waf-1 expression by lumi- studies indicate that lumican plays an important role in determining can, which in turn enhanced colony formation of tumor cells in soft the structural phenotype of the mature collagen fibril in various agar. tissues. Decorin is also a member of the small leucine-rich proteogly- can protein family, and the phenotypes of decorin-deficient mice were very similar to those of lumican-targeted mice (7, 8). Decorin is MATERIALS AND METHODS emerging as a powerful modulator of cell growth by affecting several key elements, including matrix assembly, growth factor binding, and Proteins and Antibodies. DMEM was from Sigma (St. Louis, MO). Prim- receptor tyrosine kinase activity (3, 9, 10). Suppression of decorin ers were synthesized by Genset (Kyoto, Japan). A human placenta cDNA expression was found to be related to the induction of anchorage- library constructed in the pEAK8 expression vector was obtained from Edge- independent growth caused by v-src in human fetal lung fibroblasts Bio Systems (Gaithersburg, MD). Lumican protein from bovine cornea was (11). Lumican was also shown to reduce colony formation in soft agar purchased from Sigma. Recombinant MT1-MMP, the inert mutant of MT1- MMP (MT1-E/A), and MT3-MMP catalytic domains tagged with the FLAG Received 3/24/04; revised 6/16/04; accepted 7/28/04. epitope at the COOH-terminus and purified MMP-2 protein were prepared as Grant support: Grants-in-Aid for Scientific Research from the Ministry of Education, described previously (28, 32, 33). Monoclonal antibodies against FLAG Science and Culture of Japan (B2-11240203 and 14370053; H. Sato). epitope and glutathione S-transferase (GST) were purchased from Sigma and The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with Santa Cruz Biotechnology (Santa Cruz, CA), respectively. Recombinant 18 U.S.C. Section 1734 solely to indicate this fact. TIMP-1 and TIMP-2 proteins and monoclonal antibody against MT1-MMP Requests for reprints: Hiroshi Sato, Department of Molecular Virology and Oncol- (113-5B7) were gifts from Daiichi Fine Chemical Co. Ltd. (Toyama, Japan). ogy, Cancer Research Institute, Kanazawa University, 13-1 Takara-machi, Kanazawa, Cell Culture. Human embryonic kidney HEK293, HEK293T, HeLa, and Ishikawa 920-0934, Japan. Phone: 81-76-265-2750; Fax: 81-76-234-4505; E-mail: [email protected]. fibrosarcoma HT1080 cells were obtained from American Type Culture Col- ©2004 American Association for Cancer Research. lection (Manassas, VA) and cultured in DMEM supplemented with 5% FCS. 7058 Downloaded from cancerres.aacrjournals.org on September 28, 2021. © 2004 American Association for Cancer Research. CLEAVAGE OF LUMICAN BY MT1-MMP Fig. 1. Degradation of lumican by MT-MMPs. A. The expression plasmid for lumican tagged with FLAG epitope (Lum-FLAG) or empty pSG5 plasmid (Ϫ) was cotransfected (0.4 g) with the indicated amount of MT1-MMP or E/A mutant plasmid (1.6 g) into 293T cells cultured in 35-mm diameter dishes. Total plasmid DNA was adjusted to 2 g/dish with pSG5 plasmid. At 36 hours after transfection, the culture medium was replaced with serum-free medium with or without 0.1 mol/L BB94, and cells were incubated additionally for 24 hours. Culture supernatants and cell lysates were then analyzed by Western blotting with anti-FLAG M2 antibody as described under Materials and Methods (top and middle panels). Expression of MT1-MMP was examined by Western blotting of cell lysates using anti-MT1-MMP antibody (bottom panel). B. The expression plasmid for lumican tagged with FLAG epitope (0.4 g) or empty pSG5 plasmid was cotransfected with 1.6 g of control plasmid (Lane Ϫ) or expression plasmid for MT-MMP family members, as indicated by number into 293T cells cultured in 35-mm diameter dishes. Culture supernatants and cell lysates were analyzed as described above (top and middle panels, respectively). MT-MMPs, except for MT2-MMP, were tagged with FLAG epitope and were detected in cell lysates with anti-FLAG M2 antibody together with lumican core protein (middle panel). MT2-MMP was detected with anti-MT2-MMP monoclonal antibody 162-4E3, which cross-reacted with MT3-MMP (bottom panel). Expression Cloning. Expression cloning to identify genes, the products of M2 antibody (Sigma). A lumican cDNA fragment, which has a BglII restric- which interact with MMP-2, MMP-9, or MT1-MMP, was done as described tion site in place of the stop codon, was generated by PCR with lumican cDNA previously (30). cloned in pEAK8 plasmid as a template and pEAK8 forward primer (TTCAT- Construction of an Expression Plasmid for Lumican Tagged with TCTCAAGCCTCAGACAGTGG)/flanking reverse primer with an extra BglII FLAG. An expression plasmid for lumican tagged with the FLAG epitope at site (underlined) starting at nucleotide 1098 of lumican gene (GenBank acces- the COOH-terminus was constructed to detect lumican protein by anti-FLAG sion no. U21128; AGAGATCTATTAAGAGTGACTTCGTTAGCAA). The Fig. 2. Cleavage of lumican protein by MT1- MMP. A. Lumican protein (6 g) was incubated with or without recombinant MT1-MMP catalytic domain (0.6 g) in 30 L TNC buffer containing 0.3% Brij at 37°C for 3 hours, separated on 10% SDS-PAGE, and stained with Coomassie Brilliant Blue. B. Lumican-GST fusion protein (3 g) was incubated with the indicated amount of recombi- nant MT1-MMP catalytic domain in the presence or absence of 0.1 mol/L BB-94 as described above, separated on 10% SDS-PAGE, and ana- lyzed by Western blotting with anti-GST antibody.